Purchase textbook

Stroke Prevention in Atrial Fibrillation,

Edition 1

Editors: Edited by Greg Flaker, MD

Publication Date: 04 Jun 2018

0 Reviews

Legal Considerations

Unknown accessibility

Note

This product relies on 3rd party tooling which may impact the accessibility features visible in inspection copies. All accessibility features mentioned would be present in the purchased version of the title.

Get a quick, expert overview of stroke risks among patients with treated and untreated atrial fibrillation, in addition to best practices for management and treatment of patients with atrial fibrillation to minimize stroke risks. This concise, clinically-focused resource by Dr. Greg Flaker consolidates today’s available information on this timely topic into one convenient resource, making it an ideal, easy-to-digest reference for practicing and trainee cardiologists as well as general practitioners treating and monitoring these patients.

Key Features

Covers a broad spectrum of management and treatment options for atrial fibrillation including anticoagulants, surgical and implanted devices.
Presents information on recent drug trials to keep you up to date with the latest developments.

Includes guidance on anticoagulation in special situations, such as cardioversion and ablation, in addition to atrial fibrillation treatment in patients with other medical conditions including cancer, major bleeding disorders, and renal or liver disease.

Chapter on Risk Stratification assists in identifying patients with a high risk of stroke and predicting treatment outcomes.

Chapter on The New Anticoagulation Clinic overviews best practices for patient education, compliance, follow-up monitoring, and quality assurance to aid in better patient outcomes.

About the author

Edited by Greg Flaker, MD, Professor of Medicine, Department of Cardiovascular Medicine, University of Missouri Health School of Medicine, Columbia, Missouri

1. Economic and Social Overview of Stroke Related to Atrial Fibrillation

2. Pharmacology of Anticoagulants- VKA and NOAC’s

3. Anticoagulation Drug Trials for Stroke Prevention in Atrial Fibrillation

4. Risk Stratification

5. Subclinical Atrial Fibrillation

6. The New Anticoagulation Clinic

7. Management of Bleeding Associated with Anticoagulation

8. Periprocedural Management

9. Special Situations: Anticoagulation for Cardioversion

10. Special Situations: Anticoagulation for Ablation

11. Surgical and Implanted Devices for the Left Atrial Appendage

12. Anticoagulation of the Atrial Fibrillation Patient with Other Medical Conditions

13. Stroke and Atrial Fibrillation: The Neurologist's Perspective

14. Atrial Fibrillation and Chronic Kidney Disease

Stroke Prevention in Atrial Fibrillation,

Editors: Edited by Greg Flaker, MD

Description

Key Features

About the author